Table 2. Changes in body mass of rat after treatment with galactooligosaccharides and/or bifidobacteria.
| Group | t/week | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| m/g | |||||
| Control | 44.7±1.0 | 90.8±2.7 | 147.7±5.2 | 201.4±7.4 | 230.5±6.1 |
| HP-GOS | 42.5±2.0 | 82.0±2.2 | 129.5±4.7 | 176.5±6.6 | 210.6±7.0 |
| BB | 43.5±1.5 | 88.3±3.3 | 139.6±3.1 | 193.0±7.9 | 219.0±8.2 |
| HP-GOS+BB | 45.2±1.9 | 90.3±3.3 | 147.0±5.1 | 196.6±5.8 | 224.3±6.0 |
Values are expressed as mean±standard deviation. Control=oral administration of saline, HP-GOS=oral administration of high-purity galactooligosaccharides, BB=oral administration of bifidobacteria, HP-GOS+BB=oral administration of HP-GOS and bifidobacteria